Amplidiag™ H. pylori+ClariR Read more on Amplidiag™ H. pylori+ClariR
molecular diagnostics Read more about Mobidiag
Better accessibility. Read more about Amplidiag
the game-changer Read more about Novodiag
upcoming events Read more about events
Mobidiag develops and provides innovative solutions for in vitro diagnostics of infectious diseases. Mobidiag’s products bring molecular diagnostics to an era, where improved diagnostics is accessible and affordable, without making compromises. The Amplidiag™ product line comprises products for gastrointestinal pathogens and antibiotic resistances and utilizes well-established qPCR technology for optimal performance. The new Novodiag™, announced in the spring of 2015, will complement Mobidiag’s portfolio by combining unique technological innovations packed in an integarted, fully automated diagnostic system, enabling new opportunities and new markets for molecular diagnostics.
Headquartered in Espoo, Finland, Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases. Mobidiag develops cutting-edge diagnostic platforms and test kits. Our mission is to address the unmet need for high information-density, affordable molecular diagnostic tools to enable the rapid treatment and triage of patients at the point of impact. We want to improve the quality and efficiency of healthcare and aid in the combat against spreading and emerging antimicrobial resistances. Our multi-disciplinary team of experts is dedicated to serve this mission and make an impact.
Mobidiag participates in various scientific meetings around Europe. Come and meet us to discuss the new, game-changing innovations in molecular diagnostics. See us next at the 25th ECCMID congress, which will be held from 25-28 April 2015 in Copenhagen. Among some other things you will be able to hear more about our newest diagnostic platforms – Novodiag and Amplidiag Easy.